| BRD4 Inhibitor-10 |
BRD4 INHIBITOR-10 |
1660117-38-3 |
| N-[4-(β-Cyclohexylureidoethyl)benzensulfonyl] N'-Cyclohexylurea |
格列本脲(优降糖)杂质C |
10079-35-3 |
| 2-(1-(2-morpholinoethoxy)naphthalen-4-yl)-2-oxoacetic acid |
2-(4-(2-吗啉代乙氧基)萘-1-基)-2-氧亚基乙酸 |
1023991-14-1 |
| 3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoyl
propanamide |
3-[[[2-[(氨基亚胺甲基)氨基]-4-噻唑基]甲基]亚磺酰]-N-(氨基磺酰基)丙酰胺 |
1020719-36-1 |
| 3-CHLORO-5-NITROISOQUINOLINE |
3-氯-5-硝基异喹啉 |
10296-47-6 |
| ethyl 7-bromo-3-(3-hydroxypropyl)-1H-indole-2-carboxylate |
7-溴-3-(3-羟丙基)-1H-吲哚-2-羧酸乙酯 |
1073067-97-6 |
| FaMotidine Acid IMpurity |
法莫替丁酸杂质 |
107880-74-0 |
| Sch 37370 |
乙酰地氯雷他定 |
117796-52-8 |
| 1,3-DICHLORO-5-BROMOISOQUINOLINE |
1,3-二氯-5-溴异喹啉 |
1215767-89-7 |
| MethanesulfonaMide, N-[5-[4-[5-[[(2R,6S)-2,6-diMethyl-4-Morpholinyl]Methyl]-2-oxazolyl]-1H-indazol-6-yl]-2-Methoxy-3-pyridinyl]-, rel- |
GSK2292767 |
1254036-66-2 |
| 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole |
MK-3102中间体3 |
1280210-80-1 |
| N-Des(5-Methylpyrazinecarbonyl)-N-ethylcarboxyl Glipizide |
格列吡嗪杂质H |
13554-93-3 |
| 1-P-TOLYL-1H-TETRAZOLE-5-THIOL |
5H-TETRAZOLE-5-THIONE |
13980-77-3 |
| (S)-4,6-difluoro-5-(4-(tetrahydro-2H-pyran-2-yl)phenyl)-1H-indole-3-carboxylic acid |
化合物 T24622 |
1467059-66-0 |
| (S)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one(WX191385) |
(S)-3-乙炔基-3-羟基-1-甲基吡咯烷-2-酮 |
1799615-79-4 |
| METHYL 2-(2-AMINO-1,3-THIAZOL-4-YL)-2-METHYLPROPANOATE(WX192177) |
甲基 2-(2-氨基噻唑-4-基)-2-甲基丙酯 |
1803585-37-6 |
| Pan-RAS-IN-1 |
1835283-94-7 |
1835283-94-7 |
| [2-[4-(AMinosulfonyl)phenyl]ethyl]carbaMic Acid Ethyl Ester |
[2-[4-(氨基磺酰基)苯基]乙基]氨基甲酸乙酯 |
192118-08-4 |
| Brexpiprazole Impurity 7 |
Brexpiprazole Impurity 7 |
1886188-97-1 |
| 5-HYDROXY-3,4-DIHYDRO-1H-QUINOLIN-2-ONE |
5-羟基-3,4-二氢-2-喹啉酮 |
30389-33-4 |
微信
